Erratum: Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis <i>in vivo</i>' Acta Pharmaceutica Sinica B 11 (2021) 3950-3965.

Author: Linglong DENG ¹ ; Hannah PETREK ² ; Mei-Juan TU ² ; Neelu BATRA ² ; Ai-Xi YU ¹ ; Ai-Ming YU ²
Author Information

1. Department of Orthopaedic Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan 430072, China.
2. Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Publication Type:Published Erratum
From: Acta Pharmaceutica Sinica B 2023;13(8):3577-3578
CountryChina
Language:English
Abstract: [This corrects the article DOI: 10.1016/j.apsb.2021.07.027.].